Gossamer Bio, Inc. a biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension ...
A non-profit organization that collects and analyzes Canadians' health-related data says hospitalizations for pneumonia spiked during the 2024-25 respiratory illness season. The Canadian Institute ...